Rosalind (https://www.rosalind.bio/) is the first-ever genomics analysis platform specifically designed for life science researchers to analyze and interpret datasets, by eliminating all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made a major contribution to the discovery of the double-helix structure of DNA with her famous photograph 51, OnRamp’s Rosalind™ platform aims to simplify the practice of genomic data interpretation.

Over the past two decades, research technologies such as next-generation sequencing, microarray, and mass-spectrometry have become mainstream. While these technologies have driven significant medical advances, their full potential to transform personalized medicine remains constrained by the unprecedented volume and complexities of the data being generated.

Rosalind™ overcomes a number of the limitations found in existing data analysis tools:
- Complex tools require highly-trained bioinformaticians who are constantly overextended and in high demand
- These skilled bioinformaticians spend valuable time on manual processes that could be automated so they can focus on exciting challenges and new frontiers
- Service providers and kit companies lack scalable analysis solutions for customers using their products
- Pharma experts continually articulate their need for robust, highly scalable data management solutions which enable them to securely and efficiently store, track, and share data.

The self-guided Rosalind™ platform empowers researchers to analyze their own data. For the first time, researchers performing large-scale genomics studies across a range of fields (including drug development, precision medicine, and agri-business) can rapidly and dynamically explore and interpret their own data, accelerating their next phase of research while saving time and money.

Rosalind™ guides the researcher through the entire process, from experimental design to interpretation, for analyses including transcriptomics and epigenetics.

We believe that widespread adoption of automated bioinformatic technologies will dramatically lower research costs and, ultimately, put more focus back on what to do with results, not how to get to them. With Rosalind™, we’ve evolved genomic data analysis and interpretation, so our customers can get back to revolutionizing the organic world.